MRPI Financials 07/16/2014 04:49:15 Mera Pharmace
Post# of 10
Mera Pharmaceuticals, Inc.
Period Ending Oct 31, 2011 Oct 31, 2010
Total Revenue 303 289
Cost of Revenue 16 46
Gross Profit 286 243
Operating Expenses
Research and Development 173 265
Sales, General and Admin. 306 187
Non-Recurring Items - 314
Other 8 28
Operating Income (201) (552)
Income From Continuing Operations
Add'l Income/Expense Items 5 -
Earnings Before Interest and Tax (196) (552)
Interest Expense 6 5
Earnings Before Tax (202) (557)
Income Tax (14) (19)
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (188) (538)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (188) (538)
Preferred Stock and Other Adjustments (33) (33)
Net Income Applicable to Common Shareholders (221) (571)